NASDAQ: PPBT

Purple Biotech Ltd Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: PPBT) stock is to Strong Buy PPBT stock.

Out of 2 analysts, 1 (50%) are recommending PPBT as a Strong Buy, 1 (50%) are recommending PPBT as a Buy, 0 (0%) are recommending PPBT as a Hold, 0 (0%) are recommending PPBT as a Sell, and 0 (0%) are recommending PPBT as a Strong Sell.

If you're new to stock investing, here's how to buy Purple Biotech stock.

(NASDAQ: PPBT) Purple Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Purple Biotech's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PPBT's revenue for 2026 to be $1,527,572,816, with the lowest PPBT revenue forecast at $1,527,572,816, and the highest PPBT revenue forecast at $1,527,572,816. On average, 1 Wall Street analysts forecast PPBT's revenue for 2027 to be $7,221,253,312, with the lowest PPBT revenue forecast at $7,221,253,312, and the highest PPBT revenue forecast at $7,221,253,312.

In 2028, PPBT is forecast to generate $12,022,196,448 in revenue, with the lowest revenue forecast at $12,022,196,448 and the highest revenue forecast at $12,022,196,448.

According to 2 Wall Street analysts that have issued a 1 year PPBT price target, the average PPBT price target is $10.50, with the highest PPBT stock price forecast at $11.00 and the lowest PPBT stock price forecast at $10.00.

On average, Wall Street analysts predict that Purple Biotech's share price could reach $10.50 by Mar 7, 2025. The average Purple Biotech stock price prediction forecasts a potential upside of 2,207.69% from the current PPBT share price of $0.46.

(NASDAQ: PPBT) forecast ROE is N/A, which is considered weak.